Our tissue cross-reactivity (TCR) panel tissues are collected from ethically consented, healthy human donors and processed under standardized, pathology-reviewed conditions. These tissues are specifically selected and prepared to support TCR studies, a critical component of preclinical safety assessment for biologics such as monoclonal antibodies, antibody-drug conjugates, and other targeted immunotherapies.
Each panel includes a broad range of human organs representing major systems, enabling comprehensive assessment of off-target binding and tissue-specific reactivity.
All samples are accompanied by verified histological integrity and donor metadata to support GLP and regulatory-compliant studies.